DNA編碼庫市場－全球產業規模、佔有率、趨勢、機會和預測，按產品與服務、治療領域、應用、最終用途、地區和競爭細分，2020-2030年預測

2024 年全球 DNA 編碼化合物庫 (DEL) 市值為 7.6208 億美元，預計到 2030 年將達到 16.3226 億美元，複合年成長率為 13.51%。 DEL 技術正在徹底改變早期藥物發現，它能夠同時篩選數十億種化合物，從而提高效率並加速化合物的識別。隨著製藥和生物技術公司尋求可擴展、經濟高效的生物活性分子發現平台，DEL 因其高通量能力和化學多樣性而越來越受歡迎。研發投入的增加、對個人化醫療日益成長的興趣以及對更快治療方法開發的需求繼續推動其應用。人工智慧和機器學習與 DEL 工作流程的整合進一步增強了化合物分析、先導物選擇和預測模型。隨著編碼化學和化合物支架的技術創新以及混合篩選策略的出現，DEL 市場有望持續強勁成長。

關鍵市場促進因素

對高效藥物研發方法的需求不斷成長

主要市場挑戰

庫設計與合成的複雜性

主要市場趨勢

高通量篩選技術的應用日益廣泛

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球DNA編碼圖書館市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按產品和服務（試劑盒和試劑、編碼庫、設計和合成服務、篩選服務、其他）
  • 依治療領域（腫瘤學、傳染病、心血管疾病、神經系統疾病、自體免疫疾病、代謝性疾病、其他）
  • 按應用程式（命中產生/識別、命中到先導、命中驗證/最佳化、其他）
  • 按最終用途（學術和研究機構、製藥和生物技術公司、合約研究組織、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美DNA編碼圖書館市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲DNA編碼圖書館市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區DNA編碼基因庫市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲DNA編碼圖書館市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲DNA編碼圖書館市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Merck KGaA
• GenScript Biotech Corporation
• Pharmaron Beijing Co., Ltd.
• WuXi AppTec Co., Ltd.
• Aurigene Pharmaceutical Services Limited
• BOC Sciences
• LGC Bioresearch Technologies
• SPT Labtech Ltd.
• Charles River Laboratories International, Inc.
• Life Chemicals Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

The Global DNA-encoded Library (DEL) Market was valued at USD 762.08 Million in 2024 and is projected to reach USD 1632.26 Million by 2030, growing at a CAGR of 13.51%. DEL technology is revolutionizing early-stage drug discovery by enabling simultaneous screening of billions of compounds, which enhances efficiency and accelerates hit identification. As pharmaceutical and biotech companies seek scalable, cost-effective platforms for bioactive molecule discovery, DELs are gaining traction due to their high-throughput capabilities and chemical diversity. Increased R&D investment, growing interest in personalized medicine, and the demand for faster therapeutic development continue to drive adoption. Integration of artificial intelligence and machine learning into DEL workflows further enhances compound analysis, lead selection, and predictive modeling. With technological innovations in encoding chemistries and compound scaffolds, and the emergence of hybrid screening strategies, the DEL market is poised for continued robust growth.

Key Market Drivers

Rising Demand for Efficient Drug Discovery Methods

The surge in demand for efficient drug discovery methods is a major factor driving the growth of the DEL market. Traditional drug discovery involves extensive time and financial investment, often with low success rates. DELs address this issue by enabling the rapid screening of billions of small molecules tagged with unique DNA barcodes, allowing researchers to identify promising interactions with target proteins more effectively. This method significantly reduces the time and cost associated with early-stage drug development. As pharmaceutical companies aim to speed up the development of targeted therapies for complex conditions such as cancer and neurological disorders, the scalability and precision of DEL technology offer a compelling advantage. The ability to explore vast chemical spaces and develop tailored treatments aligns with the industry's shift toward precision medicine, reinforcing DEL's role as a vital tool in modern drug discovery.

Key Market Challenges

Complexity of Library Design and Synthesis

The intricate process of designing and synthesizing DNA-encoded libraries presents a key challenge to market growth. Creating diverse libraries requires specialized expertise in conjugating small molecules with DNA tags, with multiple synthesis steps that must be precisely executed. Maintaining the fidelity and reproducibility of libraries across large datasets is a technical hurdle, as errors in encoding can lead to inaccurate screening outcomes. Additionally, balancing chemical diversity with biological compatibility limits the scope of compound design. Some complex molecules or desired modifications may be difficult to synthesize or require extensive refinement, increasing time and costs. These complexities affect consistency and scalability, especially during transition from discovery to lead optimization.

Key Market Trends

Increasing Adoption of High-Throughput Screening Technologies

High-throughput screening (HTS) technologies are becoming increasingly integrated with DEL platforms, enabling rapid evaluation of millions to billions of compounds. This combination boosts drug discovery efficiency by reducing time and cost while increasing hit identification accuracy. Advances in automation, robotics, and data analytics are optimizing HTS workflows, making them more adaptable to DEL applications. Artificial intelligence and machine learning algorithms are further enhancing analysis by improving target interaction predictions and prioritizing hits. These capabilities are essential in the discovery of novel therapeutics for oncology, infectious diseases, and neurological disorders, fueling broader market adoption.

Key Market Players

• Merck KGaA
• GenScript Biotech Corporation
• Pharmaron Beijing Co., Ltd.
• WuXi AppTec Co., Ltd.
• Aurigene Pharmaceutical Services Limited
• BOC Sciences
• LGC Bioresearch Technologies
• SPT Labtech Ltd.
• Charles River Laboratories International, Inc.
• Life Chemicals Inc.

Report Scope

In this report, the Global DNA-encoded Library Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA-encoded Library Market, By Product & Service:

• Kits & Reagents
• Encoded Libraries
• Design & Synthesis Services
• Screening Services
• Others

DNA-encoded Library Market, By Therapeutic Area:

• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Neurological Diseases
• Autoimmune Diseases
• Metabolic Diseases
• Others

DNA-encoded Library Market, By Application:

• Hit Generation / Identification
• Hit to Lead
• Hit Validation / Optimization
• Others

DNA-encoded Library Market, By End Use:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

DNA-encoded Library Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA-encoded Library Market.

Available Customizations

Global DNA-encoded Library Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global DNA-encoded Library Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Kits & Reagents, Encoded Libraries, Design & Synthesis Services, Screening Services, Others)
  • 5.2.2. By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Autoimmune Diseases, Metabolic Diseases, Others)
  • 5.2.3. By Application (Hit Generation / Identification, Hit to Lead, Hit Validation / Optimization, Others)
  • 5.2.4. By End Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America DNA-encoded Library Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Service
  • 6.2.2. By Therapeutic Area
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States DNA-encoded Library Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Service
      • 6.3.1.2.2. By Therapeutic Area
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Mexico DNA-encoded Library Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Service
      • 6.3.2.2.2. By Therapeutic Area
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Canada DNA-encoded Library Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Service
      • 6.3.3.2.2. By Therapeutic Area
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe DNA-encoded Library Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Service
  • 7.2.2. By Therapeutic Area
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France DNA-encoded Library Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Service
      • 7.3.1.2.2. By Therapeutic Area
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. Germany DNA-encoded Library Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Service
      • 7.3.2.2.2. By Therapeutic Area
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom DNA-encoded Library Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Service
      • 7.3.3.2.2. By Therapeutic Area
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy DNA-encoded Library Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Service
      • 7.3.4.2.2. By Therapeutic Area
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain DNA-encoded Library Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Service
      • 7.3.5.2.2. By Therapeutic Area
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia-Pacific DNA-encoded Library Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Service
  • 8.2.2. By Therapeutic Area
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China DNA-encoded Library Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Service
      • 8.3.1.2.2. By Therapeutic Area
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India DNA-encoded Library Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Service
      • 8.3.2.2.2. By Therapeutic Area
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. South Korea DNA-encoded Library Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Service
      • 8.3.3.2.2. By Therapeutic Area
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. Japan DNA-encoded Library Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Service
      • 8.3.4.2.2. By Therapeutic Area
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia DNA-encoded Library Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Service
      • 8.3.5.2.2. By Therapeutic Area
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. South America DNA-encoded Library Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Service
  • 9.2.2. By Therapeutic Area
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil DNA-encoded Library Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Service
      • 9.3.1.2.2. By Therapeutic Area
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina DNA-encoded Library Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Service
      • 9.3.2.2.2. By Therapeutic Area
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia DNA-encoded Library Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Service
      • 9.3.3.2.2. By Therapeutic Area
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. Middle East and Africa DNA-encoded Library Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Service
  • 10.2.2. By Therapeutic Area
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa DNA-encoded Library Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Service
      • 10.3.1.2.2. By Therapeutic Area
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia DNA-encoded Library Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Service
      • 10.3.2.2.2. By Therapeutic Area
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE DNA-encoded Library Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Service
      • 10.3.3.2.2. By Therapeutic Area
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Merck KGaA
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. GenScript Biotech Corporation
• 14.3. Pharmaron Beijing Co., Ltd.
• 14.4. WuXi AppTec Co., Ltd.
• 14.5. Aurigene Pharmaceutical Services Limited
• 14.6. BOC Sciences
• 14.7. LGC Bioresearch Technologies
• 14.8. SPT Labtech Ltd.
• 14.9. Charles River Laboratories International, Inc.
• 14.10. Life Chemicals Inc.

15. Strategic Recommendations

16. About Us & Disclaimer